Genes, diet and inflammatory bowel disease.

Area of Science:

• Genetics and Immunology
• Gastroenterology
• Nutrigenetics

Background:

• Inflammatory bowel disease (IBD) is linked to genetic predispositions, involving polymorphisms in genes like CARD15, ATG16L1, and HBD.
• Aberrant immune responses to gut bacteria, influenced by genetic variants in MHC, TLRs, IL23R, DLG5, SLC22A4/5, and ABCB1, contribute to chronic gut inflammation.
• While pharmacogenetics is established, nutrigenetics presents a significant potential for IBD management.

Purpose of the Study:

• To explore the genetic underpinnings of inflammatory bowel disease (IBD).
• To investigate the role of genetic polymorphisms in immune responses to gut microbiota.
• To highlight the potential of nutrigenetics in managing IBD through diet-gene interactions.

Main Methods:

• Review of existing literature on genetic polymorphisms associated with IBD.
• Analysis of gene variants affecting immune responses, mucosal function, and transporter activity.
• Exploration of dietary interventions, including elemental diets, probiotics, prebiotics, and immunonutrition.

Main Results:

• Specific gene polymorphisms (e.g., CARD15, ATG16L1) are more prevalent in IBD patients.
• Variants in genes like IL23R may offer protection against IBD.
• Dietary interventions, such as elemental diets and immunonutrition, can modulate cytokine response and gut microbiota.

Conclusions:

• Genetic factors significantly contribute to IBD development and susceptibility.
• Nutrigenetic strategies, including targeted dietary interventions, show promise for personalized IBD management.
• Further research combining human studies and experimental models is needed to optimize nutrigenetic approaches for IBD.